Medpace Holdings Inc. (MEDP)
NASDAQ
Closed
Aug 24, 2026
Day's Range
610.1452 wk Range
373.00Profile - MEDP - Medpace Holdings Inc.
Profile
Mic Code
XNGS
Sector
Healthcare
Industry
Diagnostics & Research
Employees
6.30K
Medpace Holdings is a global, full-service clinical contract research organization that provides outsourced drug development and clinical trial services to biotechnology, pharmaceutical, and medical device companies. The firm specializes in comprehensive clinical development support across phases I through IV, offering services including clinical trial management, regulatory affairs, patient recruitment and retention, data management, medical writing, pharmacovigilance, bioanalytical laboratory services, and imaging capabilities. Medpace serves small and midsize biopharmaceutical sponsors that lack internal capacity to conduct trials independently, as well as larger pharmaceutical firms seeking specialized expertise. Operating across North America, Europe, Asia, South America, Africa, and Australia, Medpace combines scientific expertise with operational excellence to accelerate drug development timelines. Founded in 1992 and headquartered in Cincinnati, Ohio, the company supports the global outsourcing environment for clinical research and development, helping sponsors navigate complex regulatory requirements and bring new therapeutics to market efficiently.
Profile Details
Type
Common Stock
Ceo
Dr. August James Troendle M.D.
Address
5375 Medpace Way
City
Cincinnati
State
OH
Zip
45227
Country
United States
Phone
513 579 9911
Key Executives - MEDP - Medpace Holdings Inc.
Key executives
Cross Listings - MEDP - Medpace Holdings Inc.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
